Related Experiment Video
Updated: Jan 14, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Dexmedetomidine for Emergence Delirium and Agitation in Preschool Children Undergoing Adeno-Tonsillectomy: A Scoping
Simon Hanssen1, Sara Ali Abdul-Mahdi Hadi1, Felix Haidl1
1Department of Anaesthesiology and Intensive Care, Akershus University Hospital, Lørenskog, Norway.
Insights
This scoping review examines dexmedetomidine for preventing emergence delirium (ED) and agitation (EA) in preschool children after adenotonsillectomy. It maps current evidence and identifies gaps for this high-risk group.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
Background:
- Emergence delirium (ED) and emergence agitation (EA) are common postoperative behavioral disturbances in children.
- Preschool-aged children (1-6 years) undergoing adenotonsillectomy are a high-risk group for ED/EA.
- Dexmedetomidine, an α2-adrenergic agonist, shows promise for ED/EA prevention and management, but evidence in this specific pediatric subgroup is fragmented.
Purpose of the Study:
- To conduct a scoping review mapping and characterizing the existing body of evidence on dexmedetomidine use for preventing or managing ED/EA.
- To focus specifically on preschool children (1-6 years) undergoing adenotonsillectomy.
- To identify evidence patterns, gaps, and inform future research and clinical practice.
Main Methods:
- A comprehensive scoping review following JBI methodology and PRISMA-ScR guidelines.
- Searches across multiple databases (MEDLINE, Embase, CINAHL, CENTRAL) and grey literature.
- Independent screening and data extraction by two reviewers, focusing on dexmedetomidine administration, outcomes, and adverse events.
Main Results:
- Data will be charted on dexmedetomidine dosing, routes, and timing.
- The review will analyze effects on ED/EA, secondary outcomes, and adverse events.
- A descriptive synthesis will highlight evidence patterns and gaps in the literature.
Conclusions:
- This review will provide the first consolidated overview of dexmedetomidine use for ED/EA in preschool children undergoing adenotonsillectomy.
- Findings aim to inform clinical practice regarding perioperative dexmedetomidine use.
- The results will guide the design of future targeted clinical trials in this population.
Abstract:
Emergence delirium (ED) and emergence agitation (EA) are behavioural disturbances in the early postoperative period in children. Preschool-aged children (1-6 years) undergoing adeno-tonsillectomy constitute a high-risk group. The α2-adrenergic agonist dexmedetomidine has emerged as a potential preventive/therapeutic agent for ED/EA, but evidence in this specific subgroup is fragmented. To map and characterise the body of evidence regarding dexmedetomidine use for preventing or managing ED/EA in preschool children undergoing adeno-tonsillectomy. A scoping review will be conducted in accordance with JBI methodology and reported via the PRISMA-ScR checklist. Searches will be performed in MEDLINE, Embase, CINAHL, CENTRAL, and grey literature. Eligible studies will include preschool (1-6 years) children undergoing adeno-tonsillectomy where dexmedetomidine was used perioperatively. Two reviewers will screen and extract data independently. Data will be charted on dexmedetomidine dosing, routes, timing, outcome definitions, effects on ED/EA, secondary outcomes, and adverse events. A descriptive synthesis will identify evidence patterns and gaps. This review will provide the first consolidated overview of dexmedetomidine use specifically in preschool children undergoing adeno-tonsillectomy for ED/EA prevention or management. The findings may inform clinical practice and guide future targeted trials.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Inhalational Anesthetics: Overview
Drug Dosing: Infants and Children
Direct-Acting Cholinergic Agonists: Therapeutic Uses

